CLINICAL_TRIALS trial_result · 2011-05-24

Clinical Trial Update: Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy [Phase 3]

Phase 3 trial comparing ZD6474 with erlotinib in non-small cell lung cancer after prior chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Genzyme, a Sanofi Company | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-05-24